Cargando…
Clinical characteristics of anti‐MDA5 antibody‐positive interstitial lung disease
Clinically amyopathic dermatomyositis (CADM) with anti‐melanoma differentiation‐associated gene 5 antibody is associated with rapidly progressive interstitial lung disease (RP‐ILD) which results in up to 50% mortality, especially within six months of diagnosis. However, limited data are available on...
Autores principales: | Kaenmuang, Punchalee, Navasakulpong, Asma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734424/ https://www.ncbi.nlm.nih.gov/pubmed/33343905 http://dx.doi.org/10.1002/rcr2.701 |
Ejemplares similares
-
Short-Term Lung Function Changes and Predictors of Progressive Systemic Sclerosis–Related Interstitial Lung Disease
por: Kaenmuang, Punchalee, et al.
Publicado: (2020) -
Efficacy of whole lung lavage in pulmonary alveolar proteinosis: a 20-year experience at a reference center in Thailand
por: Kaenmuang, Punchalee, et al.
Publicado: (2021) -
Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies
por: Hiramatsu, Toshiya, et al.
Publicado: (2022) -
Erythematous auricular papules in the fatal cases of anti-MDA5 antibody-positive interstitial lung disease
por: Intapiboon, Porntip, et al.
Publicado: (2020) -
Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis
por: Sakamoto, Noriho, et al.
Publicado: (2018)